| Abstrakt: |
Biomarkers, Cancer, Diagnostics and Screening, Drugs and Therapies, Health and Medicine, Immunology, Oncology KIF22 could be used as a pan-cancer biomarker for clinical diagnosis, therapeutic schedule, prognosis, and cancer monitoring." Keywords: Biomarkers; Cancer; Diagnostics and Screening; Drugs and Therapies; Health and Medicine; Immunology; Oncology EN Biomarkers Cancer Diagnostics and Screening Drugs and Therapies Health and Medicine Immunology Oncology 1374 1374 1 06/19/23 20230623 NES 230623 2023 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in cancer. [Extracted from the article] |
